Pharma Deals Review, Vol 2009, No 10 (2009)

Font Size:  Small  Medium  Large

GSK Signs Cancer Deal with SuperGen

Taskin Ahmed

Abstract


SuperGen has signed a multi-year collaboration deal with GlaxoSmithKline to discover and develop cancer therapeutics based on epigenetic targets.



Add comment

Creative Commons License
This work is licensed under a Creative Commons Attribution 3.0 License.